DrugInformer Search

Oxaliplatin Related Neuropathy peripheral

Official Government Database Reports461
Online Conversations2

Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients. To view the active ingredient report, please click here.

Tell us about your Experience with Oxaliplatin

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Pain, Neuropathy peripheral

Posted By Anonymous in drugs.com on March 18, 2014 @ 12:00 am

... I was completely unaware before and when having treatment that this condition could happen post ceasing course of treatment. Unfortunately some days walking becomes extremely painful and is a huge s...

Druginformer Identified Side Effects: Feeling cold, Neuropathy peripheral

Posted By bjw1982 in www.dailystrength.org

lots of bad side effects. senstivity to cold liquids, low neurtrofill counts (ended up takiing injections of Neuprogin for that. Still have neuropathy and taking meds for that. Its getting a little bi...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.